Kinetic analysis of HER2-binding ABY-025 Affibody molecule using dynamic PET in patients with metastatic breast cancer

BACKGROUND: High expression of human epidermal growth factor receptor type 2 (HER2) represents an aggressive subtype of breast cancer. Anti-HER2 treatment requires a theragnostic approach wherein sufficiently high receptor expression in biopsy material is mandatory. Heterogeneity and discordance of...

Descripción completa

Detalles Bibliográficos
Autores principales: Alhuseinalkhudhur, Ali, Lubberink, Mark, Lindman, Henrik, Tolmachev, Vladimir, Frejd, Fredrik Y., Feldwisch, Joachim, Velikyan, Irina, Sörensen, Jens
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7085990/
https://www.ncbi.nlm.nih.gov/pubmed/32201920
http://dx.doi.org/10.1186/s13550-020-0603-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7085990/
https://www.ncbi.nlm.nih.gov/pubmed/32201920
http://dx.doi.org/10.1186/s13550-020-0603-9

Ejemplares similares